Jpmorgan Chase & Co »

Ligand Pharmaceuticals In shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Ligand Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Ligand Pharmaceuticals In held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ligand Pharmaceuticals In by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2012-06-30 $191k 12k 15.38
2010-12-31 $167k 19k 8.94

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Nvidia Corporation Common (NVDA)
Meta Platforms Common (META)
Unitedhealth Group Common (UNH)
Vanguard Total Intl Bond Etf Fund (BNDX)
Alphabet Common (GOOG)
Eli Lilly & Co Common (LLY)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Abbvie Common (ABBV)
Vanguard Total Bond Market Fund (BND)
Tesla Common (TSLA)

View all positions for Jpmorgan Chase & Co

Top funds holding Ligand Pharmaceuticals In

Vanguard Group
Henderson Group
Dimensional Fund Advisors
St. Denis J. Villere & Co
Pacer Advisors
Standard Life Aberdeen
Rice Hall James & Associates
Chicago Capital
Impax Asset Management Group
William Blair Investment Management
Deutsche Bank Aktiengesellschaft
Charles Schwab Investment Management
Bank of New York Mellon
Man Group
Kornitzer Capital Management

View all funds holding Ligand Pharmaceuticals In